Literature DB >> 2712703

Limb salvage despite extensive tissue loss. Free tissue transfer combined with distal revascularization.

J L Cronenwett1, M D McDaniel, R M Zwolak, D B Walsh, J R Schneider, W F Reus, L B Colen.   

Abstract

Extensive lower-extremity tissue loss may preclude limb salvage despite successful arterial reconstruction. We attempted to avoid limb loss in such patients by combining arterial bypass with microvascular free tissue transfer. Fourteen patient (12 diabetic), 33 to 74 years of age, presented with extensive tissue loss in 15 lower extremities, exposing bone or tendon on the heel, ankle, lower part of the leg, or hindfoot. Mean ulcer size was 5 X 8 cm. Four patients had had previous contralateral below-knee amputations. Femorodistal (seven), popliteal-distal (three), or femoropopliteal (four) bypass, or tibial angioplasty (one), was performed to provide sufficient inflow for free tissue transfer. Serratus anterior, scapular, latissimus dorsi, rectus abdominis, gracilis, ulnar, or temporalis free flaps were used. One free flap failed due to venous thrombosis and was corrected with a second flap. Limb salvage was achieved in 14 (93%) of 15 limbs during a mean follow-up of 24 months. The single amputation occurred due to severe foot ischemia in a patient whose femorodistal bypass remained patent only to the viable free flap. The remaining 13 patients (14 limbs) became ambulatory, including those with free flaps to weight-bearing regions.

Entities:  

Mesh:

Year:  1989        PMID: 2712703     DOI: 10.1001/archsurg.1989.01410050099020

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  2 in total

1.  Microvascular free myocutaneous flap for treatment of nonhealing ischemic ulcers of the lower extremity. A case report.

Authors:  C Del Campo; E A Tovar
Journal:  Tex Heart Inst J       Date:  1996

2.  Outcome of arterial reconstruction and free-flap coverage in diabetic foot ulcers: long-term results.

Authors:  Caren Randon; Frank Vermassen; Bart Jacobs; Frederik De Ryck; Koenraad Van Landuyt; Yoeri Taes
Journal:  World J Surg       Date:  2010-01       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.